Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 12:49 pm Purchase | 13G | MIRUM PHARMACEUTICALS INC MIRM | EVENTIDE ASSET MANAGEMENT LLC | 2,693,581 5.78% | 636,581 (+30.95%) | View |
| 2024-02-13 5:09 pm Purchase | 13G | MIRUM PHARMACEUTICALS INC MIRM | VANGUARD GROUP INC | 2,476,244 5.31% | 2,476,244 (New Position) | View |
| 2024-01-31 2:08 pm Purchase | 13G | MIRUM PHARMACEUTICALS INC MIRM | BlackRock Inc. BLK | 2,532,642 5.4% | 854,735 (+50.94%) | View |
| 2023-12-29 4:01 pm Sale | 13D | MIRUM PHARMACEUTICALS INC MIRM | New Enterprise Associates 16 L.P. | 0 0% | -2,186,243 (Position Closed) | View |
| 2023-09-18 4:35 pm Purchase | 13G | MIRUM PHARMACEUTICALS INC MIRM | BIOTECHNOLOGY VALUE FUND L P | 4,370,024 9.4% | 4,370,024 (New Position) | View |
| 2023-09-05 3:11 pm Purchase | 13D | MIRUM PHARMACEUTICALS INC MIRM | Frazier Life Sciences IX L.P. | 6,226,392 13.4% | 1,815,285 (+41.15%) | View |
| 2023-06-23 2:32 pm Sale | 13D | MIRUM PHARMACEUTICALS INC MIRM | New Enterprise Associates 16 L.P. | 2,186,243 5.8% | -2,000,000 (-47.78%) | View |
| 2023-05-03 4:58 pm Sale | 13G | MIRUM PHARMACEUTICALS INC MIRM | Flynn James E | 0 0% | -2,032,335 (Position Closed) | View |
| 2023-04-14 12:45 pm Purchase | 13D | MIRUM PHARMACEUTICALS INC MIRM | Frazier Life Sciences IX L.P. | 4,411,107 11.6% | 549,326 (+14.22%) | View |
| 2023-03-08 2:15 pm Sale | 13G | MIRUM PHARMACEUTICALS INC MIRM | BlackRock Inc. BLK | 1,677,907 4.6% | -458,770 (-21.47%) | View |
| 2023-02-14 3:00 pm Purchase | 13G | MIRUM PHARMACEUTICALS INC MIRM | Rock Springs Capital Management LP | 1,795,733 4.87% | 256,919 (+16.70%) | View |
| 2023-02-14 1:34 pm Purchase | 13G | MIRUM PHARMACEUTICALS INC MIRM | EVENTIDE ASSET MANAGEMENT LLC | 2,057,000 5.6% | 2,057,000 (New Position) | View |
| 2023-02-10 09:34 am Unchanged | 13G | MIRUM PHARMACEUTICALS INC MIRM | Flynn James E | 2,032,335 5.51% | 0 (Unchanged) | View |
| 2023-02-03 4:27 pm Purchase | 13G | MIRUM PHARMACEUTICALS INC MIRM | BlackRock Inc. BLK | 2,136,677 5.8% | 2,136,677 (New Position) | View |
| 2022-12-01 11:07 am Sale | 13D | MIRUM PHARMACEUTICALS INC MIRM | RiverVest Venture Fund IV L.P. | 1,621,118 4.4% | -300,000 (-15.62%) | View |
| 2022-09-12 5:23 pm Sale | 13G | MIRUM PHARMACEUTICALS INC MIRM | Flynn James E | 2,032,335 5.53% | -1,250,577 (-38.09%) | View |
| 2022-08-18 1:30 pm Sale | 13D | MIRUM PHARMACEUTICALS INC MIRM | Novo Holdings A/S | 1,760,000 4.8% | -129,127 (-6.84%) | View |
| 2022-08-16 12:20 pm Purchase | 13D | MIRUM PHARMACEUTICALS INC MIRM | Frazier Life Sciences IX L.P. | 3,861,781 10.5% | 294,869 (+8.27%) | View |
| 2022-08-02 3:31 pm Sale | 13D | MIRUM PHARMACEUTICALS INC MIRM | Novo Holdings A/S | 1,889,127 5.9% | -310,873 (-14.13%) | View |
| 2022-04-08 2:49 pm Sale | 13D | MIRUM PHARMACEUTICALS INC MIRM | Novo Holdings A/S | 2,200,000 6.9% | -245,147 (-10.03%) | View |